Baby undergoes surgery in the womb to correct intestinal malformation

Groundbreaking surgery was performed on a baby still in its mother’s womb to correct a rare birth defect. The pioneering procedure, which took place in November 2023, was led by a medical team in the United States while the mother was 26 weeks pregnant. The mother, Maisie Savage, from London, traveled to Texas for treatment, which resulted in the birth of her son, Theo, now five months old, in February 2024. The baby is healthy and developing well.
Theo was born with gastroschisis, a condition in which the abdominal wall does not close properly, causing the intestines to develop outside the body. During the surgical intervention, doctors partially exposed the mother’s uterus and gently repositioned the baby’s organs back into the abdomen using video surgery. This was the third case in the world to be successfully treated in this type of unprecedented clinical trial, making Theo the first British baby to receive intrauterine treatment for complex gastroschisis.
Maisie, 29, and Josh French, 36, Theo’s parents and teachers, expressed immense relief at the success of the pioneering operation. Maisie described her son as “a little miracle”, aware that the outcome could have been drastic. Gastroschisis is a serious defect that affects around one in every 3,000 newborns in the UK each year. In milder situations, babies may require weeks in intensive care and feeding via tube or intravenously, in addition to corrective surgery.
For more complex cases, like Theo’s, the consequences are considerably more serious, and can include up to six months in neonatal intensive care, multiple surgeries, intravenous feeding for up to two years and, in some scenarios, the need for an intestinal transplant. Even with the highest level of medical care, one in ten babies with the condition does not survive.
Theo’s parents were initially unaware of the fetal condition. Josh reported that the shock of discovering gastroschisis during his 20-week ultrasound was “incredibly scary.” After the diagnosis of a more serious, complex gastroschisis at 24 weeks of gestation, specialists at Great Ormond Street Hospital (GOSH), in London, referred the case to Texas Children’s Hospital, in Houston.
At this American hospital, a team of fetal and pediatric surgeons, under the leadership of Dr. Michael Belfort, was conducting the first-of-its-kind clinical trial for the prenatal repair of complex gastroschisis. Dr. Belfort, who had also pioneered similar intrauterine surgical procedures for babies with spina bifida, became the study’s lead author.
Maisie was told she would need to immediately travel to Texas and remain there until the end of her pregnancy, a decision she described as “huge”. As part of the trial protocol, she first traveled to Leuven Hospital in Belgium, where experts administered a Botox injection through the uterus into Theo’s abdominal wall to relax the muscles and facilitate the repair.
The family then headed to Texas, where the surgery took place in November 2023. Josh described the wait during the procedure as agonizing. “The length of that day felt like a week,” he said, reflecting on the uncertainty of the process.
During surgery, Maisie’s uterus was partially exposed for proper positioning, amniotic fluid was drained and replaced with carbon dioxide gas (CO2) to expand the operative space. Using minimally invasive surgery, Theo’s organs were repositioned inside his abdomen, which was then closed with stitches.

After the procedure, Maisie was left with a scar twice the size of a C-section scar. Unlike other women recovering from a cesarean section, she would still need to carry the baby for another 14 weeks. She said Theo often kicked her, causing pain in the scar, and described the recovery as difficult but “worth it”.
The operation was completely successful, and Theo was carried to full term and was born vaginally in Texas in February 2024. Dr. Belfort, chief of obstetrics and gynecology at Texas Children’s Hospital, expressed great satisfaction with the results. He praised the mother, the baby, the surgery and the fact that there were no complications during or after the fetal procedure, calling the result “simply remarkable.”
Paolo de Coppi, professor of pediatric surgery at GOSH and head of stem cell and regenerative medicine at University College London, hopes to be able to perform the procedure in the UK if the clinical trial is successful. He expressed hope that this option will be available to a greater number of patients soon.
Dr. Belfort is excited about the collaboration and believes the partnership between Texas Children’s and GOSH will form a formidable team. The doctor already sees the next innovations. He stated that “the inside of the uterus is now a new surgical space for innovation”, suggesting that intrauterine heart and lung surgeries could be performed in the future.
Back in London, Maisie says Theo is developing amazingly. “Everything they did just reversed what could have been a really horrible start in life, and he’s the best. He’s essentially a completely normal baby.”
Josh added: “We both feel incredibly lucky. The impact they have had on us as a family is unbelievable. They made us feel so welcome, from the staff at Great Ormond Street to Dr Belfort and his team. While we were there the level of care was incredible, and they made a very traumatic time in our lives so much easier, and we have this little man – we couldn’t be happier.”







